STAT

NOVEMBER 7, 2024

For months, as human cases of H5N1 bird flu associated with an outbreak of the virus in U.S. dairy cattle have mounted, one question has loomed larger than others: how many human infections are getting missed? Farmworkers face some of the most intense exposure to the bird flu virus, but resistance from farmers and a lack of health insurance and paid sick leave in the industry have limited the amount of testing of workers and hampered public health officials’ ability to track where the vir

Insurance 145

Insurance 145

Pharmacy Times

NOVEMBER 7, 2024

In addition to GLP-1s, dual GLP-1 and GIP agonists, intestinal lipase inhibitors, sympathomimetics, and other agents can help patients lose weight.

144

144

STAT

NOVEMBER 7, 2024

Dear Readers, If you’re reading this, you have likely received letters from me before, highlighting STAT’s coverage of health and medicine and appealing to you to consider becoming a subscriber. I’m here to do so again. This time, though, feels different: We are at a unique moment in our country’s history, when an understanding of the issues that STAT covers is more relevant than ever before — to both our personal lives and our professional lives.

135

135

Pharmacy Times

NOVEMBER 7, 2024

Children with certain atopic conditions, including asthma and common food allergies, were observed to have a higher risk of developing the chronic disorder.

123

123

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

NOVEMBER 7, 2024

Tattoos are often seen as powerful expressions of individuality. In the medical world, however, they can serve as unwanted reminders of a difficult past. For cancer patients who require radiation therapy, permanent tattoos have long been necessary to help doctors accurately target and deliver treatment. While seemingly insignificant, these permanent spots can remind many patients of their cancer journey every time they see themselves in the mirror.

124

124

pharmaphorum

NOVEMBER 7, 2024

Discover the key takeaways from a webinar focused on boosting recruitment and retention through Social Determinants of Health (SDOH) data. Learn how incorporating SDOH data can enhance your recruitment and retention strategies.

111

111

Drug Topics

NOVEMBER 7, 2024

Researchers attempted to understand the evolving epidemiology of gastrointestinal stromal tumors in major organ sites.

112

112

Fierce Pharma

NOVEMBER 7, 2024

After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring. | After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting to restructuring, cutting the autoimmune disease biotech's workforce for a second time in less than a year.

107

107

pharmaphorum

NOVEMBER 7, 2024

Novo Nordisk has abandoned a drug it licensed from KBP Biosciences last year in a deal valued at up to $1.3 billion after it missed the mark in a chronic kidney disease (CKD) trial.The Danish group bought rights to ocedurenone, an oral non-steroidal mineralocorticoid receptor antagonist (nsMRA), from the Singapore biotech in October 2023 as a companion to its GLP-1-based therapies for reducing cardiovascular risk and kidney disease in people with diabetes and obesity.

105

105

STAT

NOVEMBER 7, 2024

In the last year, drugmakers have talked up the prospect of medicines discovered or designed by artificial intelligence.

127

127

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 7, 2024

Efforts include a mandatory intravenous immunoglobulin ordering form, blood bank gatekeeping, and a stewardship committee to ensure optimized use.

107

107

Drug Topics

NOVEMBER 7, 2024

Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.

98

98

Fierce Pharma

NOVEMBER 7, 2024

Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its bread-and-butter antirival franchise with an eye on the potential of its long-acting | Gilead's CAR-T therapies Yescarta and Tecartus have stayed relatively flat all year with its Yescarta facing a 1% decline over the third quarter due to competition.

106

106

pharmaphorum

NOVEMBER 7, 2024

NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis

105

105

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

BioPharm

NOVEMBER 7, 2024

Under an agreement, Leads Biolabs has granted the new company, Oblenio Bio, an exclusive option to license LBL-051, a tri-specific T-cell engager antibody.

98

98

Fierce Pharma

NOVEMBER 7, 2024

An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) Elevidys has sparked a new surge in sales for the gene therapy. | An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy Elevidys has sparked a new surge in sales. The gene therapy's $181 million sales in the third quarter beat analysts' expectations as it made a 48% sequential leap.

FDA 98

FDA 98

Pharmaceutical Technology

NOVEMBER 7, 2024

The company reported that it does not have sufficient cash reserves to operate for the next 12 months, can only fund operations into Q1 2025.

98

98

Drug Topics

NOVEMBER 7, 2024

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses a recent meta-analysis that evaluated the efficacy, safety, and clinical implications of insulin icodec.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

NOVEMBER 7, 2024

The EMA has granted approval for Sanofi/Regeneron’s Dupixent (dupilumab) to treat EoE in children as young as one.

105

105

Pharmacy Times

NOVEMBER 7, 2024

RSV vaccines were 80% effective in preventing hospitalization, ICU admission, and death among adults aged 60 years and older.

Vaccines 132

Vaccines Hospitals 132

pharmaphorum

NOVEMBER 7, 2024

Sarepta has halted development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy therapy Exondys 51.

111

111

Pharmacy Times

NOVEMBER 7, 2024

Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.

94

94

Pharmaceutical Technology

NOVEMBER 7, 2024

Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

98

98

Pharmacy Times

NOVEMBER 7, 2024

Evidence shows that the agent is not an effective nasal decongestant.

FDA 153

FDA 153

Outsourcing Pharma

NOVEMBER 7, 2024

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

93

93

Fierce Healthcare

NOVEMBER 7, 2024

CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims to better manage specialty drug spending. | CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims to better manage specialty drug spending.

Specialty Pharmacies 70

Specialty Pharmacies Independent Pharmacies 70

Outsourcing Pharma

NOVEMBER 7, 2024

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults with relapsed or treatment resistant tumors.

75

75

Fierce Healthcare

NOVEMBER 7, 2024

Venture capital firm General Catalyst's Health Assurance Transformation Corporation (HATCo) signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday. | Venture capital firm General Catalyst's Health Assurance Transformation Corporation signed a definitive agreement to buy Summa Health for $485 million, the organizations announced Thursday.

67

67

Fierce Pharma

NOVEMBER 7, 2024

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. | Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the same. But the Massachusetts biotech's RSV shot fell way short of expectations.

Vaccines 81

Vaccines 81

The FDA Law Blog

NOVEMBER 7, 2024

By Véronique Li, Senior Medical Device Regulation Expert & Jeffrey N. Gibbs — In most instances, it is clear if a product will be considered a “device” under the Federal Food, Drug, and Cosmetic Act (FD&C Act). Sometimes, though, the question of classification defies an easy answer. When a company is unsure if its product is a device, there are a number of resources that can provide the answer, such as the device regulations at 21 CFR parts 800 – 898; any of the databases that cover pr

FDA 62

FDA Documentation Labelling 62

Pharmacy Times

NOVEMBER 7, 2024

Lerodalcibep is a novel, third-generation, anti-PCSK9 therapy small binding protein.

94

94

Fierce Healthcare

NOVEMBER 7, 2024

At the Coalition for Health AI’s Global Summit in Las Vegas, CHAI members gathered to tease out some of the most basic questions about their proposed national network of AI assurance labs | At the CHAI Global Summit in Las Vegas in October, CHAI members openly debated about who would use the assurance labs and who would pay for model validation, among other fundamental questions.

62

62

pharmaphorum

NOVEMBER 7, 2024

Nasdaq-listed CDMO Avid Bioservices has agreed a $1.

108

108